dapagliflozin propanediol monohydrate
A hydrate that consists of dapagliflozin compounded with (S)-propylene glycol and hydrate in a (1:1:1) ratio. Used to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
Term info
dapagliflozin propanediol monohydrate
- (2S)-propane-1,2-diol--(1S)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol--water (1/1/1)
3_STAR
0
C24H35ClO9
chebi_ontology
dapagliflozin (S)-propylene glycol hydrate, Dapagliflozin propanediol, Dapagliflozin S-propylene glycol monohydrate, Dapagliflozin mixture with propylene glycol, hydrate, Forxiga, Farxiga, Dapagliflozin propylene glycolate hydrate, BMS-512148-05
CHEBI:85079
InChI=1S/C21H25ClO6.C3H8O2.H2O/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21;1-3(5)2-4;/h3-8,10,17-21,23-26H,2,9,11H2,1H3;3-5H,2H2,1H3;1H2/t17-,18-,19+,20-,21+;3-;/m10./s1
GOADIQFWSVMMRJ-UPGAGZFNSA-N
502.98200
502.19696
O.C[C@H](O)CO.CCOc1ccc(Cc2cc(ccc2Cl)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1
Term relations
- hydrate
- has part some dapagliflozin
- has part some (S)-propane-1,2-diol
- has role some hypoglycemic agent
- has role some sodium-glucose transport protein subtype 2 inhibitor